BMJ  2006;332:1461-1462 (24 June), doi:10.1136/bmj.332.7556.1461

Editorial

Drugs for anovulatory infertility in polycystic ovary syndrome

Reserve metformin for second line treatment for women with clomifene resistance

The first 150 words of the full text of this article appear below.

Polycystic ovary syndrome is the commonest cause of anovulatory infertility and is managed with numerous drugs.¹ Before starting drug treatment, women should be helped to optimise their body weight to improve the chance of spontaneous ovulation and natural conception, improve the chance of successful response to ovulation induction drugs, and maximise their health in pregnancy.

Extremes of opinion on weight loss have been eloquently outlined: Balen and colleagues suggested that drug treatment should be withheld from women with a body mass index greater than 35 owing to the dangers of pregnancy in obese women,² and Laredo emphasised the concern of stigmatising overweight women by such withholding of fertility treatment.³ Options for drug treatment may seem more straightforward, but a multicentre placebo controlled trial of metformin reported in this week's BMJ by Moll and colleagues (p 1485) challenges that view.⁴

First line drug treatment for women with the . . . [Full text of this article]

Department of Obstetrics and Gynaecology, Faculty of Medicine, Cairo University, Cairo 111451, Egypt
(kaainih@link.net)

Department of Obstetrics and Gynaecology, University of Auckland, Private Bag 92 019, Auckland, New Zealand

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

Etelka Moll, Patrick M M Bossuyt, Johanna C Korevaar, Cornelis B Lambalk, and Fulco van der Veen
BMJ 2006 332: 1485. [Abstract] [Full Text] [PDF]

Please do not resuscitate: Communication is key

Gordon Lishman
BMJ 2006 332: 609. [Extract] [Full Text]

Should obese women with polycystic ovary syndrome receive treatment for infertility?

Adam H Balen, Martin Dresner, Eleanor M Scott, and James O Drife
BMJ 2006 332: 434-435. [Extract] [Full Text] [PDF]

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Jonathan M Lord, Ingrid H K Flight, and Robert J Norman
BMJ 2003 327: 951. [Abstract] [Full Text] [PDF]